A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
Clinical trial NCT05568706 · COMPLETED
Trial details
- NCT number
- NCT05568706
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2025-06-23
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.